ensartinib 100 MG Oral Capsule [Ensacove]
- RxCUI
- 2712640
- RxNorm name
- ensartinib 100 MG Oral Capsule [Ensacove]
- Display name
- ensartinib 100 MG Oral Capsule [Ensacove]
- Full name
- ensartinib 100 MG Oral Capsule [Ensacove]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ENSACOVE | ENSARTINIB | Xcovery Holdings, Inc. | 1e1b2f79-678a-472a-b924-66909c8a4b2e | 2026-02-17 | Warnings, Adverse reactions | 2712640 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1e1b2f79-678a-472a-b924-66909c8a4b2e | Ensacove 100 MG Oral Capsule [PSN] · ensartinib 100 MG Oral Capsule [Ensacove] [SBD] · Ensacove 100 MG (as ensartinib hydrochloride 113 MG) Oral Capsule [SY] | 3 | 5 | These highlights do not include all the information needed to use ENSACOVE safely and effectively. See full prescribing information for ENSACOVE. ENSACOVE TM (ensartinib) capsules, for oral use Initial U.S. Approval: 2024 | 20260217 |